About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

HLH Patients - a Retrospective Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05531721

HLH Patients - a Retrospective Study

Monocentric, observational, retrospective, no profit study aimed to analyze factors that are significantly impacting the outcome of patients diagnosed with HLH.

Lead sponsor: Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna

retrospective data collection to study: type of HLH familial vs secondary, sex, age, presence of infectious cause, involvement central nervous system ( SNC), hepatic involvement, presence of hemophagocytosis, presence of splenomegaly, presence of involvement of other organs, the value of neutrophils (PMN), the value of hemoglobin, platelets, albumin, triglycerides, ferritin, LDH, type of therapy and the response to therapy after 2 months

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Have received HLH diagnosis according to HLH 2004 criteria
•age ⥶18 years.
•followed at our facility between January 2004 and December 2021
•Whose parents have consented to participation and data processing

Related studies

RECRUITINGPhase 2

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

NCT06160791 · Hemophagocytic Lymphohistiocytoses

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT04902807 · Autoimmune Lymphoproliferative Syndrome, Autoimmune Cytopenia, and more

Prospective Validation of the OHI Index

NCT05882175 · HLH, Hemophagocytic Lymphohistiocytoses, and more

Active Not RecruitingNA

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

NCT05236764 · Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, and more

Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis

NCT06047210 · Hemophagocytic Lymphohistiocytoses

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 25, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment39

Start dateNov 2022

Last updatedMay 25, 2023

Condition

Hemophagocytic Lymphohistiocytoses

Locations shown

AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita

Turin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 25, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions